
The FDA approved the first heart valve designed to expand after surgery as a child grows.
The Autus valve is approved for pediatric patients with congenital pulmonary valve disease needing pulmonary valve replacement, not every childhood heart defect.
Some children develop substantial backward leakage through the pulmonary valve, which can weaken or enlarge the right ventricle over time.
A balloon catheter can widen the valve from about 13 millimeters to as much as 22 millimeters, potentially reducing repeat open-heart surgeries.
The valve’s polymeric leaflets control blood flow; the FDA called it the first U.S.-approved heart valve using polymer instead of animal-derived tissue.
In the first 60 patients, six-month results showed acceptable right-sided blood flow and no more than mild backward leakage through the valve.
Three patients had valve-frame fractures and two had reduced leaflet movement; none caused symptoms. Longer-term evaluation is continuing.
Read the FDA’s official notice for the approved population, study findings, reported device problems, and ongoing evaluation.